How representative are data from global trials on programmed death-1 blockade in melanoma?

Br J Dermatol. 2022 Sep;187(3):283-284. doi: 10.1111/bjd.21621. Epub 2022 May 4.

Authors

Patrick Schummer¹, Bastian Schilling¹

Affiliation

¹ Department of Dermatology, Venereology and Allergology, University Hospital Würzburg, Würzburg, Germany.

PMID: 35508326
DOI: 10.1111/bjd.21621

No abstract available

Publication types

Comment

MeSH terms

B7-H1 Antigen
Humans
Immunotherapy
Melanoma* / drug therapy
Programmed Cell Death 1 Receptor

Substances

B7-H1 Antigen
Programmed Cell Death 1 Receptor